-
GDC-0068 (RG7440) Pan-AKT Inhibitor Guide
2026-08-20
GDC-0068, also known as RG7440, is an ATP-competitive pan-AKT inhibitor for studying PI3K/Akt/mTOR-driven cancer biology. The compound inhibits Akt1, Akt2, and Akt3, shows reported antitumor activity in xenograft models, and requires solvent-specific handling because it is insoluble in water.
-
RNA Pol II Inhibition and Active Cell Death
2026-08-20
Harper et al. show that RNA Pol II inhibition kills cells through an active apoptotic program triggered by loss of hypophosphorylated RNA Pol IIA, rather than through passive depletion of transcripts and proteins. The study defines the Pol II degradation-dependent apoptotic response (PDAR) and provides an experimental framework for distinguishing transcriptional shutdown from regulated cell death in cancer research.
-
Torin2: A Selective mTOR Inhibitor for Cancer Research
2026-08-19
Torin2 is a potent mTOR inhibitor with reported subnanomolar activity, cellular kinase selectivity, and oral bioavailability. Its strongest applications are pathway-dissection studies, medullary thyroid carcinoma models, viability and migration assays, and carefully controlled apoptosis assay workflows.
-
Cyanine 5-dCTP Workflows for DNA Labeling
2026-08-19
Cyanine 5-dCTP enables direct red-fluorescent labeling during enzymatic DNA synthesis, supporting PCR, probe generation, sequencing, and imaging workflows. This guide combines practical starting conditions with the latest DNA-framework findings to improve incorporation, cleanup, signal quality, and assay interpretation.
-
Wnt-C59 as a Causal Probe of Wnt10a Secretion
2026-08-18
Wnt-C59 is a potent PORCN inhibitor for testing whether exosomal Wnt10a secretion causally drives β-catenin-dependent osteogenesis. This article translates recent BMSC findings into a rigorous assay strategy while defining implications for cancer biology.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-08-18
Turn a chemically diverse natural product library into a staged workflow for enzyme inhibition, parasite phenotyping, and pathway-level validation. This practical guide combines the DiscoveryProbe Natural Product Library Plus with lessons from recent CpAdhE research to improve hit triage, reproducibility, and troubleshooting.
-
Flubendazole as an Autophagy Assay Lens
2026-08-17
Flubendazole can serve as a controlled perturbation for testing how autophagy intersects with tumor-microenvironment signaling. This article translates breast cancer extracellular-vesicle findings into a rigorous assay framework without confusing an autophagy tool with a validated treatment mechanism.
-
P2RX1, Calcium, and Mitochondrial Apoptosis in Ph+ ALL
2026-08-17
This 2025 study identifies P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking purinergic signaling to calcium imbalance, CaMKII activation, PI3K/Akt suppression, and mitochondrial apoptosis. Its findings provide a mechanistic framework for interpreting cell-death responses in Ph+ ALL models while highlighting the need for validation beyond a single engineered cell line.
-
VX-661 and the Next Era of CFTR Rescue
2026-08-16
VX-661 offers more than a folding-rescue readout. By linking F508del CFTR correction to calnexin-dependent proteostasis, variant-aware phenotyping, and exposure sequencing, translational teams can build more predictive cystic fibrosis workflows.
-
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-08-15
The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, linking its activity to renal fibrosis, inflammation, epithelial–mesenchymal transition, and Smad3/STAT3 signaling. By testing two SMYD2-directed compounds in animal and tubular epithelial cell models, the work provides a mechanistic framework for evaluating epigenetic intervention in treatment-associated kidney injury.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-14
The Phenomics protocol by Zhao and colleagues establishes a standardized whole-blood platform for testing how metabolic interventions alter stimulus-specific immune responses. Its main contribution is the integration of controlled immune stimulation, pathway-directed metabolic modulation, and cytokine quantification in fresh human blood, creating a practical framework for reproducible cohort studies.
-
Chemerin–cNTS Signaling Raises Sympathetic Activity
2026-08-14
Hao and colleagues show that chemerin signaling in the caudal nucleus tractus solitarius increases renal sympathetic nerve activity, arterial pressure, and heart rate through CMKLR1-dependent NADPH oxidase activation and superoxide production. Pharmacological pathway testing further implicates NMDA, rather than AMPA/kainate, receptor transmission in the downstream paraventricular nucleus, clarifying how an adipokine can influence central cardiovascular control.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-13
Build a dual-readout mRNA delivery assay that separates cellular uptake from productive translation. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking with EGFP expression for nanoparticle validation, macrophage targeting, and faster troubleshooting.
-
FH1 for iPS-Derived Hepatocyte Maturation
2026-08-13
FH1 is a practical small-molecule option for improving functional readouts during iPS cell differentiation to hepatocytes, with reported gains in albumin secretion, CYP3A4, colony morphology, and reduced AFP. This guide translates those findings into a controlled iHep workflow and shows how the reference study’s light-regulated translation strategy can inform, but not replace, FH1 assay design.
-
Balsalazide disodium: Workflows for IBD Research
2026-08-12
Balsalazide disodium supports colon-focused inflammation research, from water-based assay preparation to radiolabeled imaging in ulcerative colitis models. Its practical differentiation is the combination of a 5-aminosalicylic acid prodrug design, aqueous solubility, and a reference workflow that achieved high ulcerated-colon uptake in mice.